logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. A randomized, prospective evaluation of an interventional program to discontinue intravenous antibiotics at two tertiary care teaching institutions.

    Article - En anglais

    To evaluate a program to discontinue intravenous antibiotics at two teaching hospitals, 102 inpatients meeting eligibility criteria were randomly assigned to two groups.

    In one group, patients'physicians were contacted by pharmacists with recommendations to discontinue intravenous antibiotic therapy ; in the other, patients were simply observed.

    Measured outcomes were antibiotic costs, length of stay, need to restart intravenous antibiotics, in-hospital mortality, and 30-day readmissions.

    The intervention significantly reduced mean antibiotic costs per patient ($19.82 vs $35.84, p=0.03), but related labor costs exceeded this benefit.

    Readmissions were significantly more frequent in the intervention group than in the control group (29% vs 9.8% p=0.02), but they were not infection related.

    No impact was demonstrated on the other measured outcomes.

    Institutions considering such programs or with one in place should conduct similar evaluations.

    Mots-clés Pascal : Antibiotique, Analyse coût efficacité, Arrêt traitement, Infection, Chimiothérapie, Traitement, Coût global, Forme parentérale, Voie intraveineuse, Randomisation, Economie santé, Prospective, Centre hospitalier universitaire, Diminution coût, Homme

    Mots-clés Pascal anglais : Antibiotic, Cost efficiency analysis, Withdrawal, Infection, Chemotherapy, Treatment, Life cycle cost, Parenteral form, Intravenous administration, Randomization, Health economy, Prospective, Teaching hospital, Cost lowering, Human

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0269344

    Code Inist : 002B30A01C. Création : 15/07/1997.